Karachi, IBL HealthCare Ltd. (IBLHL), a significant player in Pakistan's pharmaceutical sector, has declared a combined dividend of 30% for the fiscal year ending in February 2024. The company, which has been listed on the Pakistan Stock Exchange since 2009, boasts a paid-up capital of Rs. 856.75 million and has demonstrated a solid financial standing with an EPS of Rs. 4.33 for 2022/2023. The dividend, announced on October 21, 2023, includes both cash and bonus shares, reinforcing IBL HealthCare Ltd.'s strategy of rewarding its shareholders while maintaining a strong growth trajectory.